Sysmex Corporation (TYO:6869)
Japan
· Delayed Price · Currency is JPY 2,482.00
+14.50 (0.59%)
Jun 27, 2025, 3:30 PM JST
Sysmex Revenue
In the fiscal year ending March 31, 2025, Sysmex had annual revenue of 508.64B JPY with 10.21% growth. Sysmex had revenue of 141.78B in the quarter ending March 31, 2025, with 5.03% growth.
Revenue
508.64B
Revenue Growth
+10.21%
P/S Ratio
3.02
Revenue / Employee
50.65M
Employees
10,042
Market Cap
1,536.53B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 508.64B | 47.13B | 10.21% |
| Mar 31, 2024 | 461.51B | 51.01B | 12.43% |
| Mar 31, 2023 | 410.50B | 46.72B | 12.84% |
| Mar 31, 2022 | 363.78B | 58.71B | 19.24% |
| Mar 31, 2021 | 305.07B | 3.09B | 1.02% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Takeda Pharmaceutical Company | 4,581.55B |
| Daiichi Sankyo Company | 1,886.26B |
| HOYA Corporation | 866.03B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Shionogi & | 438.27B |
Sysmex News
- 6 weeks ago - Sysmex GAAP EPS of Yen 86.05, revenue of Yen 508.6B - Seeking Alpha
- 4 months ago - Sysmex reports 9M results - Seeking Alpha
- 8 months ago - Sysmex GAAP EPS of ¥41.70, revenue of ¥242.48B - Seeking Alpha